NT5E and pancreatic neoplasm: The utilization of CRISPR/Cas9 methodology to disrupt the CD73 gene in both human and murine cellular models of pancreatic cancer demonstrated that CD73 inactivation impeded cellular proliferation and motility, leading to a halt in the G1 phase of the cell cycle.